Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Health Catalyst, Inc. Announces Preliminary Q4 Revenue Above Midpoint Range Of $70.1M-$75.1M Est.; FY23 Revenue Above Midpoint Range Of $291.1M-$296M Est.

Author: Benzinga Newsdesk | January 08, 2024 05:06pm

Posted In: HCAT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist